Cholangiocarcinoma is the most frequent biliary malignancy. It is difficult to diagnose owing
to its anatomic location, growth patterns and lack of definite diagnostic criteria. Currently …

Abstract Purpose of Review Cholangiocarcinoma is a rare biliary adenocarcinoma
associated with poor outcomes. Cholangiocarcinoma is subdivided into extrahepatic and …

PURPOSE To develop an evidence-based clinical practice guideline to assist in clinical
decision making for patients with resected biliary tract cancer. METHODS ASCO convened …

Hilar cholangiocarcinoma (HC) is a rare disease with a poor prognosis which typically
presents in the 6th decade of life. Of the 3,000 cases seen annually in the United States, less …

Cholangiocarcinoma (CCC) is the most aggressive malignant tumor of the biliary tract.
Perihilar CCC (pCCC) is the most common CCC and is burdened by a complicated …

Background Cholangiocarcinoma (CCA) is associated with poor survival and therapeutic
nihilism. To date, there has not been an examination of the surgical management of CCA at …

OBJECTIVES: Current staging systems for perihilar cholangiocarcinoma (pCCA) are
inadequate, as they are based on surgical pathology and therefore not relevant to …

Primary sclerosing cholangitis (PSC) can lead to the development of cholangiocarcinoma
(CCA). The tumor may present as an intrahepatic focal cholangiocellular carcinoma but …

Background Cholangiocarcinoma is the most common primary tumor of the biliary tract
although it accounts for only 2% of all human malignancies. We herein review hilar …

Background The prognosis of hilar cholangiocarcinoma is dismal although aggressive
surgery including major hepatectomy has been performed. The aim of this study was to …